Evidence map›Paper›PMID 27504003›Full record

Trial reportHeart (British Cardiac Society)2016

Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.

Kenneth Mangion, David Carrick, Barry W Hennigan, Alexander R Payne, John McClure, Maureen Mason, Rajiv Das, Rebecca Wilson, Richard J Edwards, Mark C Petrie and 4 more

Open access · hybridAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Heart (British Cardiac Society), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Impact of complete revascularisation in relation to left ventricular function in patients with ST-segment elevation myocardial infarction and multivessel disease: a post hoc analysis of the COMPLETE randomised trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kenneth MangionBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
David CarrickBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Barry W HenniganBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Alexander R PayneBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
John McClureBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Maureen MasonWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Dunbartonshire, UK.
Rajiv DasTherapeutics and Cardiac Research Team, Freeman Hospital, Newcastle upon Tyne, UK.
Rebecca WilsonTherapeutics and Cardiac Research Team, Freeman Hospital, Newcastle upon Tyne, UK.
Richard J EdwardsTherapeutics and Cardiac Research Team, Freeman Hospital, Newcastle upon Tyne, UK.
Mark C PetrieBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Margaret McEntegartWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Dunbartonshire, UK.
Hany EteibaWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Dunbartonshire, UK.
Keith G OldroydBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Colin BerryBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Golden Jubilee National Hospital · GBUniversity of Glasgow · GBFreeman Hospital · GB

Funding

British Heart Foundation FS/15/54/31639British Heart Foundation PG/11/2/28474British Heart Foundation PG/14/97/31263Medical Research Council MR/N003403/1
6 · The paper itself

Abstract

objectiveWe hypothesised that, compared with culprit-only primary percutaneous coronary intervention (PCI), additional preventive PCI in selected patients with ST-elevation myocardial infarction with multivessel disease would not be associated with iatrogenic myocardial infarction, and would be associated with reductions in left ventricular (LV) volumes in the longer term.

methodsIn the preventive angioplasty in myocardial infarction trial (PRAMI; ISRCTN73028481), cardiac magnetic resonance (CMR) was prespecified in two centres and performed (median, IQR) 3 (1, 5) and 209 (189, 957) days after primary PCI.

resultsFrom 219 enrolled patients in two sites, 84% underwent CMR. 42 (50%) were randomised to culprit-artery-only PCI and 42 (50%) were randomised to preventive PCI. Follow-up CMR scans were available in 72 (86%) patients. There were two (4.8%) cases of procedure-related myocardial infarction in the preventive PCI group. The culprit-artery-only group had a higher proportion of anterior myocardial infarctions (MIs) (55% vs 24%). Infarct sizes (% LV mass) at baseline and follow-up were similar. At follow-up, there was no difference in LV ejection fraction (%, median (IQR), (culprit-artery-only PCI vs preventive PCI) 51.7 (42.9, 60.2) vs 54.4 (49.3, 62.8), p=0.23), LV end-diastolic volume (mL/m

conclusionsCompared with culprit-only PCI, non-infarct-artery MI in the preventive PCI strategy was uncommon and LV volumes and ejection fraction were similar.

Indexed as

Ventricular Function, LeftVentricular RemodelingAdultAgedAged, 80 and overAnterior Wall Myocardial InfarctionCoronary AngiographyCoronary Artery DiseaseFemaleHumansIatrogenic DiseaseMagnetic Resonance ImagingMaleMiddle AgedMyocardiumPercutaneous Coronary Intervention

Identifiers

PMID27504003
PMCPMC5256395
OpenAlexW2503988521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.